Clinical utility in maximizing CD34+ cell count in stem cell grafts.
about
Tissue engineering for the oncologic urinary bladder.Tissue-engineered urinary conduits.Development of a new G-CSF product based on biosimilarity assessment.Characterization of clonogenic progenitors in autologous peripheral blood stem cell grafts: evaluation of a simple in vitro assay suitable for routine clinical use.Sheep CD34+ amniotic fluid cells have hematopoietic potential and engraft after autologous in utero transplantation.
P2860
Clinical utility in maximizing CD34+ cell count in stem cell grafts.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Clinical utility in maximizing CD34+ cell count in stem cell grafts.
@ast
Clinical utility in maximizing CD34+ cell count in stem cell grafts.
@en
type
label
Clinical utility in maximizing CD34+ cell count in stem cell grafts.
@ast
Clinical utility in maximizing CD34+ cell count in stem cell grafts.
@en
prefLabel
Clinical utility in maximizing CD34+ cell count in stem cell grafts.
@ast
Clinical utility in maximizing CD34+ cell count in stem cell grafts.
@en
P356
P1433
P1476
Clinical utility in maximizing CD34+ cell count in stem cell grafts.
@en
P2093
P304
P356
10.1002/STEM.170373
P577
1999-01-01T00:00:00Z